nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—KCNJ1—appendage—sarcoma	0.0404	0.369	CbGeAlD
Glimepiride—Gliclazide—VEGFA—sarcoma	0.0223	1	CrCbGaD
Glimepiride—KCNJ11—mammary gland—sarcoma	0.0119	0.109	CbGeAlD
Glimepiride—ABCC8—mammary gland—sarcoma	0.011	0.1	CbGeAlD
Glimepiride—KCNJ11—hematopoietic system—sarcoma	0.00726	0.0664	CbGeAlD
Glimepiride—ABCC8—seminal vesicle—sarcoma	0.00704	0.0643	CbGeAlD
Glimepiride—ABCC8—smooth muscle tissue—sarcoma	0.00589	0.0539	CbGeAlD
Glimepiride—KCNJ11—lymphoid tissue—sarcoma	0.00511	0.0467	CbGeAlD
Glimepiride—CYP2C9—mammary gland—sarcoma	0.00491	0.0449	CbGeAlD
Glimepiride—KCNJ11—tendon—sarcoma	0.00481	0.0439	CbGeAlD
Glimepiride—ABCC8—testis—sarcoma	0.00367	0.0335	CbGeAlD
Glimepiride—CYP2C9—hematopoietic system—sarcoma	0.00299	0.0273	CbGeAlD
Glimepiride—KCNJ11—lymph node—sarcoma	0.00289	0.0264	CbGeAlD
Glimepiride—Increased appetite—Epirubicin—sarcoma	0.00248	0.00286	CcSEcCtD
Glimepiride—Diabetes mellitus—Doxorubicin—sarcoma	0.00248	0.00286	CcSEcCtD
Glimepiride—Confusional state—Mitoxantrone—sarcoma	0.00248	0.00285	CcSEcCtD
Glimepiride—Decreased appetite—Thiotepa—sarcoma	0.00247	0.00285	CcSEcCtD
Glimepiride—Menopausal symptoms—Epirubicin—sarcoma	0.00247	0.00284	CcSEcCtD
Glimepiride—Thrombocytopenia—Vincristine—sarcoma	0.00247	0.00284	CcSEcCtD
Glimepiride—Hepatic function abnormal—Doxorubicin—sarcoma	0.00247	0.00284	CcSEcCtD
Glimepiride—Anaphylactic shock—Mitoxantrone—sarcoma	0.00246	0.00283	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Thiotepa—sarcoma	0.00246	0.00283	CcSEcCtD
Glimepiride—Decreased appetite—Dactinomycin—sarcoma	0.00245	0.00283	CcSEcCtD
Glimepiride—Fatigue—Thiotepa—sarcoma	0.00245	0.00282	CcSEcCtD
Glimepiride—Hyperhidrosis—Vincristine—sarcoma	0.00244	0.00281	CcSEcCtD
Glimepiride—Dermatitis bullous—Epirubicin—sarcoma	0.00244	0.00281	CcSEcCtD
Glimepiride—Fatigue—Dactinomycin—sarcoma	0.00243	0.0028	CcSEcCtD
Glimepiride—Shock—Mitoxantrone—sarcoma	0.00242	0.00278	CcSEcCtD
Glimepiride—Thrombocytopenia—Mitoxantrone—sarcoma	0.00241	0.00277	CcSEcCtD
Glimepiride—Anorexia—Vincristine—sarcoma	0.0024	0.00277	CcSEcCtD
Glimepiride—Hepatic failure—Doxorubicin—sarcoma	0.0024	0.00276	CcSEcCtD
Glimepiride—Tachycardia—Mitoxantrone—sarcoma	0.0024	0.00276	CcSEcCtD
Glimepiride—Hypoglycaemia—Epirubicin—sarcoma	0.00239	0.00275	CcSEcCtD
Glimepiride—Cerebrovascular accident—Epirubicin—sarcoma	0.00238	0.00274	CcSEcCtD
Glimepiride—Hyperhidrosis—Mitoxantrone—sarcoma	0.00238	0.00274	CcSEcCtD
Glimepiride—Hypotension—Vincristine—sarcoma	0.00236	0.00271	CcSEcCtD
Glimepiride—Feeling abnormal—Thiotepa—sarcoma	0.00234	0.0027	CcSEcCtD
Glimepiride—Anorexia—Mitoxantrone—sarcoma	0.00234	0.0027	CcSEcCtD
Glimepiride—Hyponatraemia—Epirubicin—sarcoma	0.00234	0.0027	CcSEcCtD
Glimepiride—Pain in extremity—Epirubicin—sarcoma	0.00233	0.00268	CcSEcCtD
Glimepiride—Feeling abnormal—Dactinomycin—sarcoma	0.00233	0.00268	CcSEcCtD
Glimepiride—Gastrointestinal pain—Thiotepa—sarcoma	0.00233	0.00268	CcSEcCtD
Glimepiride—Anaemia—Etoposide—sarcoma	0.00231	0.00267	CcSEcCtD
Glimepiride—Gastrointestinal pain—Dactinomycin—sarcoma	0.00231	0.00266	CcSEcCtD
Glimepiride—Hot flush—Doxorubicin—sarcoma	0.00231	0.00266	CcSEcCtD
Glimepiride—Hypotension—Mitoxantrone—sarcoma	0.0023	0.00264	CcSEcCtD
Glimepiride—Increased appetite—Doxorubicin—sarcoma	0.0023	0.00264	CcSEcCtD
Glimepiride—Menopausal symptoms—Doxorubicin—sarcoma	0.00229	0.00263	CcSEcCtD
Glimepiride—Insomnia—Vincristine—sarcoma	0.00228	0.00263	CcSEcCtD
Glimepiride—Paraesthesia—Vincristine—sarcoma	0.00227	0.00261	CcSEcCtD
Glimepiride—Urticaria—Thiotepa—sarcoma	0.00226	0.0026	CcSEcCtD
Glimepiride—Dermatitis bullous—Doxorubicin—sarcoma	0.00226	0.0026	CcSEcCtD
Glimepiride—Abdominal pain—Thiotepa—sarcoma	0.00225	0.00259	CcSEcCtD
Glimepiride—Leukopenia—Etoposide—sarcoma	0.00224	0.00258	CcSEcCtD
Glimepiride—Abdominal pain—Dactinomycin—sarcoma	0.00223	0.00257	CcSEcCtD
Glimepiride—Hypoglycaemia—Doxorubicin—sarcoma	0.00221	0.00255	CcSEcCtD
Glimepiride—Paraesthesia—Mitoxantrone—sarcoma	0.00221	0.00254	CcSEcCtD
Glimepiride—Loss of consciousness—Etoposide—sarcoma	0.0022	0.00253	CcSEcCtD
Glimepiride—Cerebrovascular accident—Doxorubicin—sarcoma	0.0022	0.00253	CcSEcCtD
Glimepiride—Decreased appetite—Vincristine—sarcoma	0.00219	0.00253	CcSEcCtD
Glimepiride—Dyspnoea—Mitoxantrone—sarcoma	0.00219	0.00252	CcSEcCtD
Glimepiride—Somnolence—Mitoxantrone—sarcoma	0.00218	0.00252	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Vincristine—sarcoma	0.00218	0.00251	CcSEcCtD
Glimepiride—Fatigue—Vincristine—sarcoma	0.00218	0.0025	CcSEcCtD
Glimepiride—Convulsion—Etoposide—sarcoma	0.00217	0.0025	CcSEcCtD
Glimepiride—Hyponatraemia—Doxorubicin—sarcoma	0.00217	0.00249	CcSEcCtD
Glimepiride—Dyspepsia—Mitoxantrone—sarcoma	0.00216	0.00249	CcSEcCtD
Glimepiride—Hypertension—Etoposide—sarcoma	0.00216	0.00249	CcSEcCtD
Glimepiride—Pain in extremity—Doxorubicin—sarcoma	0.00216	0.00248	CcSEcCtD
Glimepiride—Decreased appetite—Mitoxantrone—sarcoma	0.00214	0.00246	CcSEcCtD
Glimepiride—Fatigue—Mitoxantrone—sarcoma	0.00212	0.00244	CcSEcCtD
Glimepiride—Hypersensitivity—Thiotepa—sarcoma	0.0021	0.00241	CcSEcCtD
Glimepiride—Hypersensitivity—Dactinomycin—sarcoma	0.00208	0.0024	CcSEcCtD
Glimepiride—Gastrointestinal pain—Vincristine—sarcoma	0.00206	0.00238	CcSEcCtD
Glimepiride—Confusional state—Etoposide—sarcoma	0.00206	0.00237	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00206	0.00237	CcSEcCtD
Glimepiride—Anaphylactic shock—Etoposide—sarcoma	0.00204	0.00235	CcSEcCtD
Glimepiride—Asthenia—Thiotepa—sarcoma	0.00204	0.00235	CcSEcCtD
Glimepiride—Abdominal distension—Epirubicin—sarcoma	0.00203	0.00234	CcSEcCtD
Glimepiride—Asthenia—Dactinomycin—sarcoma	0.00203	0.00233	CcSEcCtD
Glimepiride—Feeling abnormal—Mitoxantrone—sarcoma	0.00202	0.00233	CcSEcCtD
Glimepiride—Influenza—Epirubicin—sarcoma	0.00201	0.00232	CcSEcCtD
Glimepiride—Pruritus—Thiotepa—sarcoma	0.00201	0.00232	CcSEcCtD
Glimepiride—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00201	0.00231	CcSEcCtD
Glimepiride—Thrombocytopenia—Etoposide—sarcoma	0.002	0.0023	CcSEcCtD
Glimepiride—Tachycardia—Etoposide—sarcoma	0.00199	0.0023	CcSEcCtD
Glimepiride—Eosinophilia—Epirubicin—sarcoma	0.00199	0.0023	CcSEcCtD
Glimepiride—Abdominal pain—Vincristine—sarcoma	0.00199	0.0023	CcSEcCtD
Glimepiride—Hyperhidrosis—Etoposide—sarcoma	0.00198	0.00228	CcSEcCtD
Glimepiride—Angina pectoris—Epirubicin—sarcoma	0.00196	0.00226	CcSEcCtD
Glimepiride—Urticaria—Mitoxantrone—sarcoma	0.00195	0.00225	CcSEcCtD
Glimepiride—Anorexia—Etoposide—sarcoma	0.00195	0.00224	CcSEcCtD
Glimepiride—Diarrhoea—Thiotepa—sarcoma	0.00195	0.00224	CcSEcCtD
Glimepiride—Abdominal pain—Mitoxantrone—sarcoma	0.00194	0.00224	CcSEcCtD
Glimepiride—Diarrhoea—Dactinomycin—sarcoma	0.00193	0.00223	CcSEcCtD
Glimepiride—Pancytopenia—Epirubicin—sarcoma	0.00191	0.0022	CcSEcCtD
Glimepiride—Hypotension—Etoposide—sarcoma	0.00191	0.0022	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.0019	0.00219	CcSEcCtD
Glimepiride—Dizziness—Thiotepa—sarcoma	0.00188	0.00217	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—sarcoma	0.00188	0.00216	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—sarcoma	0.00186	0.00215	CcSEcCtD
Glimepiride—Pollakiuria—Epirubicin—sarcoma	0.00186	0.00214	CcSEcCtD
Glimepiride—Hypersensitivity—Vincristine—sarcoma	0.00186	0.00214	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—sarcoma	0.00185	0.00213	CcSEcCtD
Glimepiride—Photosensitivity reaction—Epirubicin—sarcoma	0.00184	0.00212	CcSEcCtD
Glimepiride—Paraesthesia—Etoposide—sarcoma	0.00184	0.00211	CcSEcCtD
Glimepiride—Weight increased—Epirubicin—sarcoma	0.00183	0.00211	CcSEcCtD
Glimepiride—Dyspnoea—Etoposide—sarcoma	0.00182	0.0021	CcSEcCtD
Glimepiride—Somnolence—Etoposide—sarcoma	0.00182	0.00209	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—sarcoma	0.00182	0.00209	CcSEcCtD
Glimepiride—Hypersensitivity—Mitoxantrone—sarcoma	0.00181	0.00208	CcSEcCtD
Glimepiride—Asthenia—Vincristine—sarcoma	0.00181	0.00208	CcSEcCtD
Glimepiride—Vomiting—Thiotepa—sarcoma	0.00181	0.00208	CcSEcCtD
Glimepiride—Drowsiness—Epirubicin—sarcoma	0.0018	0.00207	CcSEcCtD
Glimepiride—Vomiting—Dactinomycin—sarcoma	0.0018	0.00207	CcSEcCtD
Glimepiride—Rash—Thiotepa—sarcoma	0.00179	0.00207	CcSEcCtD
Glimepiride—Dermatitis—Thiotepa—sarcoma	0.00179	0.00206	CcSEcCtD
Glimepiride—Headache—Thiotepa—sarcoma	0.00178	0.00205	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00178	0.00205	CcSEcCtD
Glimepiride—Rash—Dactinomycin—sarcoma	0.00178	0.00205	CcSEcCtD
Glimepiride—Decreased appetite—Etoposide—sarcoma	0.00178	0.00205	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—sarcoma	0.00177	0.00204	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Etoposide—sarcoma	0.00176	0.00203	CcSEcCtD
Glimepiride—Asthenia—Mitoxantrone—sarcoma	0.00176	0.00203	CcSEcCtD
Glimepiride—Fatigue—Etoposide—sarcoma	0.00176	0.00203	CcSEcCtD
Glimepiride—Jaundice—Epirubicin—sarcoma	0.00175	0.00202	CcSEcCtD
Glimepiride—Diarrhoea—Vincristine—sarcoma	0.00173	0.00199	CcSEcCtD
Glimepiride—Sweating—Epirubicin—sarcoma	0.00172	0.00198	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—sarcoma	0.00172	0.00198	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—sarcoma	0.0017	0.00196	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—sarcoma	0.0017	0.00195	CcSEcCtD
Glimepiride—Nausea—Thiotepa—sarcoma	0.00169	0.00195	CcSEcCtD
Glimepiride—Feeling abnormal—Etoposide—sarcoma	0.00168	0.00194	CcSEcCtD
Glimepiride—Diarrhoea—Mitoxantrone—sarcoma	0.00168	0.00194	CcSEcCtD
Glimepiride—Nausea—Dactinomycin—sarcoma	0.00168	0.00193	CcSEcCtD
Glimepiride—Agranulocytosis—Epirubicin—sarcoma	0.00168	0.00193	CcSEcCtD
Glimepiride—Gastrointestinal pain—Etoposide—sarcoma	0.00167	0.00192	CcSEcCtD
Glimepiride—Dizziness—Vincristine—sarcoma	0.00167	0.00192	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—sarcoma	0.00166	0.00191	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00165	0.0019	CcSEcCtD
Glimepiride—Bradycardia—Epirubicin—sarcoma	0.00164	0.00189	CcSEcCtD
Glimepiride—Urticaria—Etoposide—sarcoma	0.00162	0.00187	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—sarcoma	0.00162	0.00187	CcSEcCtD
Glimepiride—Abdominal pain—Etoposide—sarcoma	0.00162	0.00186	CcSEcCtD
Glimepiride—Hepatitis—Epirubicin—sarcoma	0.00161	0.00186	CcSEcCtD
Glimepiride—Vomiting—Vincristine—sarcoma	0.0016	0.00185	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—sarcoma	0.00159	0.00183	CcSEcCtD
Glimepiride—Rash—Vincristine—sarcoma	0.00159	0.00183	CcSEcCtD
Glimepiride—Dermatitis—Vincristine—sarcoma	0.00159	0.00183	CcSEcCtD
Glimepiride—Headache—Vincristine—sarcoma	0.00158	0.00182	CcSEcCtD
Glimepiride—Vomiting—Mitoxantrone—sarcoma	0.00156	0.0018	CcSEcCtD
Glimepiride—Visual impairment—Epirubicin—sarcoma	0.00155	0.00179	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—sarcoma	0.00155	0.00179	CcSEcCtD
Glimepiride—CYP2C9—liver—sarcoma	0.00155	0.0142	CbGeAlD
Glimepiride—Rash—Mitoxantrone—sarcoma	0.00155	0.00178	CcSEcCtD
Glimepiride—Dermatitis—Mitoxantrone—sarcoma	0.00155	0.00178	CcSEcCtD
Glimepiride—Headache—Mitoxantrone—sarcoma	0.00154	0.00177	CcSEcCtD
Glimepiride—Erythema multiforme—Epirubicin—sarcoma	0.00152	0.00176	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—sarcoma	0.00152	0.00175	CcSEcCtD
Glimepiride—Hypersensitivity—Etoposide—sarcoma	0.00151	0.00173	CcSEcCtD
Glimepiride—Nausea—Vincristine—sarcoma	0.0015	0.00173	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—sarcoma	0.00149	0.00172	CcSEcCtD
Glimepiride—Asthenia—Etoposide—sarcoma	0.00147	0.00169	CcSEcCtD
Glimepiride—Nausea—Mitoxantrone—sarcoma	0.00146	0.00168	CcSEcCtD
Glimepiride—Pruritus—Etoposide—sarcoma	0.00145	0.00167	CcSEcCtD
Glimepiride—Arrhythmia—Epirubicin—sarcoma	0.00144	0.00166	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—sarcoma	0.00144	0.00166	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—sarcoma	0.00141	0.00162	CcSEcCtD
Glimepiride—Erythema—Epirubicin—sarcoma	0.0014	0.00162	CcSEcCtD
Glimepiride—Malnutrition—Epirubicin—sarcoma	0.0014	0.00162	CcSEcCtD
Glimepiride—Diarrhoea—Etoposide—sarcoma	0.0014	0.00161	CcSEcCtD
Glimepiride—Tension—Epirubicin—sarcoma	0.00138	0.00159	CcSEcCtD
Glimepiride—Nervousness—Epirubicin—sarcoma	0.00136	0.00157	CcSEcCtD
Glimepiride—Dizziness—Etoposide—sarcoma	0.00135	0.00156	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—sarcoma	0.00133	0.00153	CcSEcCtD
Glimepiride—Vision blurred—Epirubicin—sarcoma	0.00132	0.00152	CcSEcCtD
Glimepiride—Vomiting—Etoposide—sarcoma	0.0013	0.0015	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—sarcoma	0.0013	0.0015	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—sarcoma	0.0013	0.0015	CcSEcCtD
Glimepiride—Anaemia—Epirubicin—sarcoma	0.0013	0.00149	CcSEcCtD
Glimepiride—Agitation—Epirubicin—sarcoma	0.00129	0.00149	CcSEcCtD
Glimepiride—Rash—Etoposide—sarcoma	0.00129	0.00148	CcSEcCtD
Glimepiride—Dermatitis—Etoposide—sarcoma	0.00129	0.00148	CcSEcCtD
Glimepiride—Headache—Etoposide—sarcoma	0.00128	0.00147	CcSEcCtD
Glimepiride—Tension—Doxorubicin—sarcoma	0.00127	0.00147	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—sarcoma	0.00126	0.00145	CcSEcCtD
Glimepiride—Leukopenia—Epirubicin—sarcoma	0.00126	0.00145	CcSEcCtD
Glimepiride—Palpitations—Epirubicin—sarcoma	0.00124	0.00143	CcSEcCtD
Glimepiride—Loss of consciousness—Epirubicin—sarcoma	0.00123	0.00142	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—sarcoma	0.00122	0.00141	CcSEcCtD
Glimepiride—Convulsion—Epirubicin—sarcoma	0.00122	0.0014	CcSEcCtD
Glimepiride—Nausea—Etoposide—sarcoma	0.00121	0.0014	CcSEcCtD
Glimepiride—Hypertension—Epirubicin—sarcoma	0.00121	0.0014	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—sarcoma	0.0012	0.00138	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—sarcoma	0.00119	0.00137	CcSEcCtD
Glimepiride—Anxiety—Epirubicin—sarcoma	0.00119	0.00137	CcSEcCtD
Glimepiride—Dry mouth—Epirubicin—sarcoma	0.00117	0.00135	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—sarcoma	0.00116	0.00134	CcSEcCtD
Glimepiride—Confusional state—Epirubicin—sarcoma	0.00116	0.00133	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—sarcoma	0.00115	0.00132	CcSEcCtD
Glimepiride—Anaphylactic shock—Epirubicin—sarcoma	0.00115	0.00132	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—sarcoma	0.00114	0.00131	CcSEcCtD
Glimepiride—Shock—Epirubicin—sarcoma	0.00113	0.0013	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—sarcoma	0.00113	0.0013	CcSEcCtD
Glimepiride—Thrombocytopenia—Epirubicin—sarcoma	0.00112	0.00129	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—sarcoma	0.00112	0.00129	CcSEcCtD
Glimepiride—Tachycardia—Epirubicin—sarcoma	0.00112	0.00129	CcSEcCtD
Glimepiride—Hyperhidrosis—Epirubicin—sarcoma	0.00111	0.00128	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—sarcoma	0.0011	0.00127	CcSEcCtD
Glimepiride—Anorexia—Epirubicin—sarcoma	0.00109	0.00126	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—sarcoma	0.00108	0.00125	CcSEcCtD
Glimepiride—Hypotension—Epirubicin—sarcoma	0.00107	0.00123	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—sarcoma	0.00107	0.00123	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—sarcoma	0.00106	0.00122	CcSEcCtD
Glimepiride—Shock—Doxorubicin—sarcoma	0.00104	0.0012	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—sarcoma	0.00104	0.0012	CcSEcCtD
Glimepiride—Insomnia—Epirubicin—sarcoma	0.00104	0.00119	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—sarcoma	0.00103	0.00119	CcSEcCtD
Glimepiride—Paraesthesia—Epirubicin—sarcoma	0.00103	0.00118	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—sarcoma	0.00102	0.00118	CcSEcCtD
Glimepiride—Dyspnoea—Epirubicin—sarcoma	0.00102	0.00118	CcSEcCtD
Glimepiride—Somnolence—Epirubicin—sarcoma	0.00102	0.00117	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—sarcoma	0.00101	0.00116	CcSEcCtD
Glimepiride—Dyspepsia—Epirubicin—sarcoma	0.00101	0.00116	CcSEcCtD
Glimepiride—Decreased appetite—Epirubicin—sarcoma	0.000996	0.00115	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—sarcoma	0.000991	0.00114	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Epirubicin—sarcoma	0.000989	0.00114	CcSEcCtD
Glimepiride—Fatigue—Epirubicin—sarcoma	0.000988	0.00114	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—sarcoma	0.000959	0.0011	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—sarcoma	0.000952	0.0011	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—sarcoma	0.000945	0.00109	CcSEcCtD
Glimepiride—Feeling abnormal—Epirubicin—sarcoma	0.000944	0.00109	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—sarcoma	0.000942	0.00109	CcSEcCtD
Glimepiride—Gastrointestinal pain—Epirubicin—sarcoma	0.000937	0.00108	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—sarcoma	0.000933	0.00107	CcSEcCtD
Glimepiride—Decreased appetite—Doxorubicin—sarcoma	0.000921	0.00106	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000915	0.00105	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—sarcoma	0.000914	0.00105	CcSEcCtD
Glimepiride—Urticaria—Epirubicin—sarcoma	0.00091	0.00105	CcSEcCtD
Glimepiride—Abdominal pain—Epirubicin—sarcoma	0.000906	0.00104	CcSEcCtD
Glimepiride—Feeling abnormal—Doxorubicin—sarcoma	0.000874	0.00101	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—sarcoma	0.000867	0.000998	CcSEcCtD
Glimepiride—Hypersensitivity—Epirubicin—sarcoma	0.000844	0.000972	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—sarcoma	0.000842	0.00097	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—sarcoma	0.000838	0.000965	CcSEcCtD
Glimepiride—Asthenia—Epirubicin—sarcoma	0.000822	0.000947	CcSEcCtD
Glimepiride—Pruritus—Epirubicin—sarcoma	0.000811	0.000933	CcSEcCtD
Glimepiride—Diarrhoea—Epirubicin—sarcoma	0.000784	0.000903	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—sarcoma	0.000781	0.000899	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—sarcoma	0.000761	0.000876	CcSEcCtD
Glimepiride—Dizziness—Epirubicin—sarcoma	0.000758	0.000872	CcSEcCtD
Glimepiride—Pruritus—Doxorubicin—sarcoma	0.00075	0.000864	CcSEcCtD
Glimepiride—Vomiting—Epirubicin—sarcoma	0.000728	0.000839	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—sarcoma	0.000725	0.000835	CcSEcCtD
Glimepiride—Rash—Epirubicin—sarcoma	0.000722	0.000832	CcSEcCtD
Glimepiride—Dermatitis—Epirubicin—sarcoma	0.000722	0.000831	CcSEcCtD
Glimepiride—Headache—Epirubicin—sarcoma	0.000718	0.000827	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—sarcoma	0.000701	0.000807	CcSEcCtD
Glimepiride—Nausea—Epirubicin—sarcoma	0.00068	0.000784	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—sarcoma	0.000674	0.000776	CcSEcCtD
Glimepiride—Rash—Doxorubicin—sarcoma	0.000668	0.00077	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—sarcoma	0.000668	0.000769	CcSEcCtD
Glimepiride—Headache—Doxorubicin—sarcoma	0.000664	0.000765	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—sarcoma	0.00063	0.000725	CcSEcCtD
